Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ORIC PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 50,782 shares of ORIC (ORIC PHARMACEUTICALS INC), worth $415,397 as of 2025-Q4. The position was increased (++118.6% shares). ORIC represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$415,397
Current Shares
50,782
Total Value Change
+$116,195
Total Shares Change
+8,462
Other major holders of ORIC: VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC
Increased |
| 50,782 |
+118.6% |
| $415,397 |
| 0.0% |
| $8.08 |
39 |
| 2025-Q3 | New | 23,235 | - | $278,820 | 0.0% | $11.62 | 32 |
| 2025-Q2 | Exited | 0 | -100.0% | $0 | 0.0% | $10.31 | 0 |
| 2025-Q1 | Increased | 509,179 | +1331.1% | $2.8M | 0.0% | $6.14 | 42 |
| 2024-Q4 | Increased | 35,579 | +54.5% | $287,122 | 0.0% | $8.17 | 33 |
| 2024-Q3 | Decreased | 23,034 | -45.6% | $236,099 | 0.0% | $10.65 | 0 |
| 2024-Q2 | New | 42,320 | - | $299,202 | 0.0% | $7.07 | 32 |